Spectrum Solutions Saliva Collection Device, Access Bio, Genalyte Coronavirus Tests Get FDA EUAs
Oct 12, 2020 | staff reporterNEW YORK — The US Food and Drug Administration on Thursday granted separate Emergency Use Authorizations (EUAs) for Spectrum Solutions' saliva collection device for SARS-CoV-2 tests, as well as SARS-CoV-2 tests developed by Access Bio and Genalyte.Spectrum's SDNA-1000 Saliva Collection Device consists of a plastic tube designed for the collection of human saliva samples suspected of containing SARS-CoV-2 RNA, a funnel, a cap with a stem flare, and a fluid chamber containing a patented stabilizing solution, according to the FDA.It has been evaluated with various RNA extraction chemistries including PerkinElmer's Chemagic Viral DNA/RNA 300 Kit, Thermo Fisher Scientific's MagMax Viral/Pathogen II Nucleic Acid Extraction Kit, Qiagen's QIAsymphony DSP Virus/Pathogen Midi Kit, and Roche's Magna Pure LC Total Nucleic Acid Isolation Kit.The device may be manufactured only by Draper, Utah-based Spectrum. It is used with DxTerity Diagnostics' DxTerity SARS-CoV-2 RT-PCR CE Test and RUCDR Infinite Biologics' saliva-based SARS-CoV-2 test.Access Bio's CareStart COVID-19 Antigen test is a visually read lateral flow immunochromatographic assay designed to detect the nucleocapsid protein antigen from SARS CoV-2 in nasopharyngeal swab specimens. Results are provided in 10 minutes, according to Access Bio.The test may be used by labs that are CLIA-certified to perform high-, moderate-, or waived-complexity tests, and is authorized for point-of-care use, the FDA said.In July, Somerset, New Jersey-based Access Bio received EUAs from the FDA for its CareStart COVID-19 IgM/IgG SARS-CoV-2 test and its CareStart COVID-19 MDx RT-PCR test. Genalyte's Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2 is designed to detect total antibodies, including immunoglobulin G and M, against the virus in whole blood, plasma, and serum. It runs on the San Diego-based company's Maverick Detection System, which uses photonic ring resonance technology for rapid blood testing.The test may be used by labs CLIA-certified to perform moderate- or high-complexity tests, according to the FDA.
- Forums
- ASX - By Stock
- AT1
- Media Update
Media Update, page-9
-
- There are more pages in this discussion • 1,837 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $14.06M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.386K | 161.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 318701 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 125713 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 318701 | 0.021 |
9 | 1005888 | 0.020 |
8 | 1130840 | 0.019 |
3 | 162414 | 0.018 |
1 | 50000 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 125713 | 2 |
0.024 | 532595 | 5 |
0.025 | 379000 | 4 |
0.026 | 415954 | 3 |
0.027 | 1093000 | 3 |
Last trade - 15.58pm 23/08/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online